UBS Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$153M Buy
505,714
+184,207
+57% +$55.7M 0.03% 553
2025
Q1
$106M Sell
321,507
-3,767
-1% -$1.25M 0.02% 702
2024
Q4
$100M Buy
325,274
+144,644
+80% +$44.6M 0.02% 715
2024
Q3
$38.3M Buy
180,630
+7,390
+4% +$1.57M 0.01% 950
2024
Q2
$48.5M Buy
173,240
+47,825
+38% +$13.4M 0.01% 781
2024
Q1
$33.5M Buy
125,415
+37,038
+42% +$9.89M 0.01% 939
2023
Q4
$20.4M Buy
88,377
+32,192
+57% +$7.45M 0.01% 1081
2023
Q3
$8.21M Buy
56,185
+32,960
+142% +$4.81M ﹤0.01% 1514
2023
Q2
$5.36M Sell
23,225
-7,698
-25% -$1.78M ﹤0.01% 1839
2023
Q1
$7.49M Sell
30,923
-65,767
-68% -$15.9M ﹤0.01% 1557
2022
Q4
$28.1M Buy
96,690
+71,227
+280% +$20.7M 0.01% 835
2022
Q3
$1.66M Buy
25,463
+7,278
+40% +$473K ﹤0.01% 2485
2022
Q2
$1.3M Sell
18,185
-11,544
-39% -$827K ﹤0.01% 2690
2022
Q1
$2.92M Buy
29,729
+7,597
+34% +$745K ﹤0.01% 2366
2021
Q4
$1.88M Buy
22,132
+518
+2% +$43.9K ﹤0.01% 2922
2021
Q3
$1.73M Buy
21,614
+15,536
+256% +$1.24M ﹤0.01% 2850
2021
Q2
$592K Sell
6,078
-10,540
-63% -$1.03M ﹤0.01% 3634
2021
Q1
$1.94M Buy
16,618
+14,212
+591% +$1.66M ﹤0.01% 2791
2020
Q4
$267K Sell
2,406
-155
-6% -$17.2K ﹤0.01% 4094
2020
Q3
$304K Buy
2,561
+72
+3% +$8.55K ﹤0.01% 3743
2020
Q2
$282K Sell
2,489
-7,099
-74% -$804K ﹤0.01% 3774
2020
Q1
$640K Buy
9,588
+8,509
+789% +$568K ﹤0.01% 3010
2019
Q4
$99K Sell
1,079
-23,511
-96% -$2.16M ﹤0.01% 4983
2019
Q3
$2.12M Buy
24,590
+13,464
+121% +$1.16M ﹤0.01% 2556
2019
Q2
$1.17M Buy
11,126
+1,548
+16% +$162K ﹤0.01% 2937
2019
Q1
$1.2M Buy
9,578
+3,645
+61% +$457K ﹤0.01% 2796
2018
Q4
$669K Sell
5,933
-1,702
-22% -$192K ﹤0.01% 3300
2018
Q3
$1.64M Sell
7,635
-1,130
-13% -$242K ﹤0.01% 2754
2018
Q2
$2.45M Sell
8,765
-29,713
-77% -$8.31M ﹤0.01% 2403
2018
Q1
$4.49M Buy
38,478
+38,291
+20,476% +$4.47M ﹤0.01% 1939
2017
Q4
$17K Sell
187
-844
-82% -$76.7K ﹤0.01% 5709
2017
Q3
$46K Buy
+1,031
New +$46K ﹤0.01% 4966
2017
Q2
Sell
-1,860
Closed -$29K 6782
2017
Q1
$29K Buy
1,860
+893
+92% +$13.9K ﹤0.01% 4979
2016
Q4
$14K Buy
967
+825
+581% +$11.9K ﹤0.01% 5770
2016
Q3
$2K Sell
142
-413
-74% -$5.82K ﹤0.01% 6461
2016
Q2
$5K Buy
555
+295
+113% +$2.66K ﹤0.01% 6219
2016
Q1
$2K Sell
260
-368
-59% -$2.83K ﹤0.01% 6432
2015
Q4
$7K Buy
628
+362
+136% +$4.04K ﹤0.01% 6187
2015
Q3
$16K Buy
266
+69
+35% +$4.15K ﹤0.01% 5618
2015
Q2
$15K Sell
197
-26
-12% -$1.98K ﹤0.01% 5716
2015
Q1
$15K Sell
223
-408
-65% -$27.4K ﹤0.01% 5606
2014
Q4
$59K Buy
+631
New +$59K ﹤0.01% 4585